Voyager Therapeutics (VYGR) EBT Margin (2015 - 2026)
Voyager Therapeutics (VYGR) posted EBT Margin of 1076.86% for Q1 2026, down 503.85% sequentially from 178.33% in Q4 2025, and down 59820.0% YoY from N/an in Q1 2025.
Voyager Therapeutics (VYGR) EBT Margin (2015 - 2026) Analysis & Trends
Voyager Therapeutics has reported EBT Margin for 12 years, with the latest figure at 1076.86% in Q1 2026.
- Quarterly EBT Margin fell 59820.0% year-over-year to 1076.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 318.94% (down 19353.0% YoY) and the FY2025 annual result came in at 296.17%, down 21575.0% from the prior year.
- EBT Margin eased to 1076.86% in Q1 2026 per VYGR's latest filing, from 178.33% in the prior quarter.
- Over five years, EBT Margin peaked at 1523.23% in Q4 2022 and troughed at 3239.97% in Q1 2022.
- A 5-year average of 498.58% and a median of 208.07% in 2025 frame the typical range for EBT Margin.
- The widest YoY moves for EBT Margin: up 569317 bps in 2022, down 189616 bps in 2022.
- Over 5 years, EBT Margin stood at 1523.23% in 2022, then sank by 96 bps to 63.5% in 2023, then tumbled by 947 bps to 538.06% in 2024, then surged by 67 bps to 178.33% in 2025, then slumped by 504 bps to 1076.86% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 1076.86%, 178.33%, and 208.07% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Voyager Therapeutics | 201.32 Mn | 84.98 Mn | - | -764.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -764.16% |
| Mar 31, 2026 | -1,076.86% |
| Dec 31, 2025 | -178.33% |
| Sep 30, 2025 | -208.07% |
| Jun 30, 2025 | -641.67% |
| Mar 31, 2025 | -478.67% |
| Dec 31, 2024 | -538.06% |
| Sep 30, 2024 | -36.55% |
| Jun 30, 2024 | -34.20% |
| Mar 31, 2024 | -58.03% |
| Dec 31, 2023 | 63.50% |
| Sep 30, 2023 | -565.19% |
| Jun 30, 2023 | -452.02% |
| Mar 31, 2023 | 82.90% |
| Dec 31, 2022 | 1,523.23% |
| Sep 30, 2022 | 42.90% |
| Jun 30, 2022 | -2,680.76% |
| Mar 31, 2022 | -3,239.97% |
| Dec 31, 2021 | 20.24% |
| Sep 30, 2021 | -5,650.27% |